Yang Yan, Chung Erwin K, Zhou Bi, Blanchong Carol A, Yu C Yung, Füst George, Kovács Margit, Vatay Agnes, Szalai Csaba, Karádi István, Varga Lilian
Center for Molecular and Human Genetics, Columbus Children's Research Institute, Ohio State University, 700 Children's Drive, Columbus, OH 43205, USA.
J Immunol. 2003 Sep 1;171(5):2734-45. doi: 10.4049/jimmunol.171.5.2734.
Among the genes and proteins of the human immune system, complement component C4 is extraordinary in its frequent germline variation in the size and number of genes. Definitive genotypic and phenotypic analyses were performed on a central European population to determine the C4 polygenic and gene size variations and their relationships with serum C4A and C4B protein concentrations and hemolytic activities. In a study population of 128 healthy subjects, the number of C4 genes present in a diploid genome varied between two to five, and 77.4% of the C4 genes belonged to the long form that contains the endogenous retrovirus HERV-K(C4). Intriguingly, higher C4 serum protein levels and higher C4 hemolytic activities were often detected in subjects with short C4 genes than those with long genes only, suggesting a negative epistatic effect of HERV-K(C4) on the expression of C4 proteins. Also, the body mass index appeared to affect the C4 serum levels, particularly in the individuals with medium or high C4 gene dosages, a phenomenon that was dissimilar in several aspects from the established correlation between body mass index and serum C3. As expected, there were strong, positive correlations between total C4 gene dosage and serum C4 protein concentrations, and between serum C4 protein concentrations and C4 hemolytic activities. There were also good correlations between the number of long genes with serum levels of C4A, and the number of short genes with serum levels of C4B. Thus, the polygenic and gene size variations of C4A and C4B contribute to the quantitative traits of C4 with a wide range of serum protein levels and hemolytic activities, and consequently the power of the innate defense system.
在人类免疫系统的基因和蛋白质中,补体成分C4在基因大小和数量的种系变异频率方面表现得极为特殊。对中欧人群进行了确定性的基因型和表型分析,以确定C4的多基因和基因大小变异及其与血清C4A和C4B蛋白浓度以及溶血活性的关系。在128名健康受试者的研究群体中,二倍体基因组中存在的C4基因数量在2至5个之间变化,并且77.4%的C4基因属于包含内源性逆转录病毒HERV-K(C4)的长形式。有趣的是,与仅具有长C4基因的受试者相比,在具有短C4基因的受试者中经常检测到更高的C4血清蛋白水平和更高的C4溶血活性,这表明HERV-K(C4)对C4蛋白的表达具有负上位效应。此外,体重指数似乎会影响C4血清水平,特别是在C4基因剂量为中等或高的个体中,这一现象在几个方面与体重指数和血清C3之间已确立的相关性不同。正如预期的那样,总C4基因剂量与血清C4蛋白浓度之间以及血清C4蛋白浓度与C4溶血活性之间存在强正相关。长基因数量与C4A血清水平之间以及短基因数量与C4B血清水平之间也存在良好的相关性。因此,C4A和C4B的多基因和基因大小变异导致了C4具有广泛血清蛋白水平和溶血活性的数量性状,从而影响了先天防御系统的功能。